Micro-PETMR
InnoStar is one of the first organizations in China to conduct safety assessment of radiopharmaceuticals. InnoStar radioisotope platform is one of the few platforms in China that is capable of conducting 3H/14C ADME, human mass balance, PET molecular imaging and preclinical pharmacogenetic, efficacy and safety assessment of radiopharmaceuticals. The platform is well equipped for sample handling and testing to conduct experiments in both rodents and non-rodents.
Radioactive class B sites
Qualified to use 31 different isotopes
InnoStar is one of the few GLP-certified organizations in China that have a radioisotope research platform and a radioactive Class B site. The platform is qualified to use 31 different isotopes. The certification has recognized InnoStar as one of the very few companies in the industry that can undertake safety evaluation of radiopharmaceuticals. Meanwhile the isotope research platform has helped differentiate InnoStar with its capability to perform pharmacokinetic and safety evaluation from its competitors in the same industry.
Address: 199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, China
Postcode: 201203
Tel: +86-21-60211999
services@innostar.cn
86-021-xxxxxxx
Scan the QR code
Subscription to our Wechat account
300012
股 票 代 码
Copyright © 2017-2021©中国·手机球探(bet007认证)官方网站-Macau App Station. All Rights Reserved. Created By VPABrand.com
